1416 Results

People

  1. Motzer
    Motzer
  2. Vickers
    Vickers
  3. Hudis
    Hudis
  4. Norton
    Norton
  5. Saltz
    Saltz
  6. O'Reilly
    O'Reilly
  7. Mao
    Mao
  8. Morris
    Morris
  9. Seidman
    Seidman
  10. Kris
    Kris

Groups

  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)
  7. Hematologic Malignancies, Division of (169)
  8. Genitourinary Oncology Service (160)
  9. Center for Hematologic Malignancies (142)
  10. Gastrointestinal Oncology Service (126)
  1. "randomized controlled trial"
Formats
  1. Journal Article (1353)
  2. Review (19)
  3. Conference Paper (17)
  4. Editorial (9)
  5. Correspondence (5)
  6. Research Letter (5)
  7. Meeting Abstract (4)
  8. Guidelines (3)
  9. Book Section (1)
Groups
  1. Department of Medicine (753)
  2. Solid Tumor Oncology Division (541)
  3. Population Sciences Research Program (259)
  4. Survivorship Research (256)
  5. Surgery (244)
  6. Epidemiology and Biostatistics (187)

More Groups

People
  1. Robert Motzer (83)
  2. Andrew Vickers (48)
  3. Larry Norton (34)
  4. Clifford Hudis (33)
  5. Leonard Saltz (32)
  6. Eileen O'Reilly (25)

More People

Years
  1. 2025 (63)
  2. 2024 (165)
  3. 2023 (110)
  4. 2022 (81)
  5. 2021 (39)
  6. 2020 (51)

More Years

Publications
  1. Journal of Clinical Oncology (164)
  2. New England Journal of Medicine (65)
  3. Lancet Oncology (46)
  4. Cancer (42)
  5. Clinical Cancer Research (42)
  6. European Urology (26)

More Publications

Publishers
  1. Elsevier Inc. (187)
  2. American Society of Clinical Oncology (170)
  3. Elsevier Science, Inc. (138)
  4. Springer (79)
  5. Lippincott Williams & Wilkins (72)
  6. Wiley Blackwell (71)

More Publishers

Results (1416)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC)
    Journal Article

    Armstrong, A. J.; Kaboteh, R.; Carducci, M. A.; Damber, J. E.; Stadler, W. M.; Hansen, M.; Edenbrandt, L.; Forsberg, G.; Nordle, T.; Pili, R.; more...
    Urologic Oncology: Seminars and Original Investigations (2014)

    Fulltext@MSK | Save
  • Investigation of novel circulating proteins, germ line single-nucleotide polymorphisms, and molecular tumor markers as potential efficacy biomarkers of first-line sunitinib therapy for advanced renal cell carcinoma
    Journal Article

    Motzer, R. J.; Hutson, T. E.; Hudes, G. R.; Figlin, R. A.; Martini, J. F.; English, P. A.; Huang, X.; Valota, O.; Williams, J. A.
    Cancer Chemotherapy and Pharmacology (2014)

    Fulltext@MSK | Save
  • Screening and prostate cancer mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
    Journal Article

    Schröder, F. H.; Hugosson, J.; Roobol, M. J.; Tammela, T. L. J.; Zappa, M.; Nelen, V.; Kwiatkowski, M.; Lujan, M.; Määttänen, L.; Lilja, H.; more...
    Lancet (2014)

    Fulltext@MSK | Save
  • Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0031
    Journal Article

    Friedman, D. L.; Chen, L.; Wolden, S.; Buxton, A.; McCarten, K.; FitzGerald, T. J.; Kessel, S.; De Alarcon, P. A.; Chen, A. R.; Kobrinsky, N.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Biomarker analyses in CLEOPATRA: A phase III, placebo-controlled study of pertuzumab in human epidermal growth factor receptor 2-positive, first-line metastatic breast cancer
    Journal Article

    Baselga, J.; Cortés, J.; Im, S. A.; Clark, E.; Ross, G.; Kiermaier, A.; Swain, S. M.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients
    Journal Article

    Stadtmauer, E. A.; Sullivan, K. M.; Marty, F. M.; Dadwal, S. S.; Papanicolaou, G. A.; Shea, T. C.; Mossad, S. B.; Andreadis, C.; Young, J. A. H.; Buadi, F. K.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100
    Journal Article

    Schneider, B. P.; Li, L.; Shen, F.; Miller, K. D.; Radovich, M.; O'neill, A.; Gray, R. J.; Lane, D.; Flockhart, D. A.; Jiang, G.; more...
    British Journal of Cancer (2014)

    Fulltext@MSK | Save
  • Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: Results from the randomised, phase 3 AFFIRM trial
    Journal Article

    Fizazi, K.; Scher, H. I.; Miller, K.; Basch, E.; Sternberg, C. N.; Cella, D.; Forer, D.; Hirmand, M.; de Bono, J. S.
    Lancet Oncology (2014)

    Fulltext@MSK | Save
  • Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): Survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response
    Journal Article

    de Azambuja, E.; Holmes, A. P.; Piccart-Gebhart, M.; Holmes, E.; Di Cosimo, S.; Swaby, R. F.; Untch, M.; Jackisch, C.; Lang, I.; Smith, I.; more...
    Lancet Oncology (2014)

    Fulltext@MSK | Save
  • EGFR expression is associated with decreased benefit from trastuzumab in the NCCTG N9831 (Alliance) trial
    Journal Article

    Cheng, H.; Ballman, K.; Vassilakopoulou, M.; Dueck, A. C.; Reinholz, M. M.; Tenner, K.; Gralow, J.; Hudis, C.; Davidson, N. E.; Fountzilas, G.; more...
    British Journal of Cancer (2014)

    Fulltext@MSK | Save